Skip to main content
Premium Trial:

Request an Annual Quote

Genome Therapeutics, Schering-Plough Extend Asthma Research Alliance

NEW YORK, Jan 2—Genome Therapeutics and Schering-Plough have extended their genomics-based research alliance for asthma drug discovery for an additional year, Genome Therapeutics said on Wednesday.


The research alliance is a multi-year program focused on discovering asthma susceptibility genes and using the data to develop preventive therapies and treatments for the disorder. The sponsored research partnership, originally scheduled to conclude at the end of 2001, will now be continued through the end of 2002.


By the terms of the agreement, Schering-Plough paid an upfront license fee, makes milestone payments, and will pay royalties on sales of any new therapeutic products. Genome Therapeutics has been paid $33 million through the deal as of Sept. 29, 2001, and may ultimately receive a total of more than $80 million, excluding royalties.


In February 2001, the two companies announced that they had discovered a new asthma susceptibility gene. The gene was discovered with Genome Therapeutics' positional cloning platform, which integrates high throughput genotyping and SNP discovery with advanced statistical genetics.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.